A case of irreversible bilateral optic damage after ethambutol therapy.
D000368:Aged; D002207:Capreomycin / Q000627:therapeutic use; D004596:Electroretinography; D004977:Ethambutol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009896:Optic Atrophy / Q000139:chemically induced* / Q000188:drug therapy; D009902:Optic Neuritis / Q000139:chemically induced* / Q000188:drug therapy; D012293:Rifampin / Q000627:therapeutic use; D012607:Scotoma / Q000139:chemically induced / Q000188:drug therapy; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014794:Visual Fields; D014803:Vitamin B Complex
D002207:Capreomycin; D014803:Vitamin B Complex; D004977:Ethambutol; D012293:Rifampin